WealthCollab’s Bristol-Myers Squibb BMY Stock Holding History

WealthCollab’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13K	Hold	37	–	–	﹤0.01%	852
2026 Q1	$2.25K	Hold	37	–	–	﹤0.01%	825
2025 Q4	$2K	Hold	37	–	–	﹤0.01%	885
2025 Q3	$1.67K	Buy	+37	New	+$1.73K	﹤0.01%	861
2025 Q2	–	Sell	-177	Closed	-$10.8K	–	963
2025 Q1	$10.8K	Buy	177 +98	+124%	+$5.71K	0.01%	454
2024 Q4	$4.47K	Hold	79	–	–	﹤0.01%	617
2024 Q3	$4.09K	Sell	79 -282	-78%	-$13.2K	﹤0.01%	657
2024 Q2	$15K	Sell	361 -192	-35%	-$8.59K	0.01%	350
2024 Q1	$30K	Buy	553 +502	+984%	+$25.6K	0.02%	224
2023 Q4	$2.62K	Buy	+51	New	+$2.68K	﹤0.01%	696

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WealthCollab's BMY Position: Q2 2026 in Review

WealthCollab held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 37 shares worth $2.13K. The position accounts for ﹤0.01% of the portfolio, ranked #852.

WealthCollab first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $30K in Q1 2024. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

WealthCollab held 37 shares of Bristol-Myers Squibb worth $2.13K as of Q2 2026.
WealthCollab left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #852 holding.
WealthCollab first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
WealthCollab's Bristol-Myers Squibb position peaked at $30K in Q1 2024.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.